Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOB | P04114 | 7/20 | 0.49 |
| ▸ | MTTP | P55157 | 6/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 10/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.47 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6645543 | 0.90 | MTTP (0.61) | APOBMTTPPTGS1 | |
| Hydrochloric Acid SCHEMBL6803931 | 0.89 | MTTP (0.60) | APOBMTTP | |
| SCHEMBL6665641 | 0.87 | APOB (0.51) | APOBMTTPRXFP1PARP10PARP11 | |
| Hydrochloric Acid SCHEMBL6662670 | 0.86 | APOB (0.50) | APOBMTTPRXFP1PARP10PARP11 | |
| SCHEMBL6662843 | 0.80 | SLC2A1 (0.49) | APOBMTTP | |
| SCHEMBL6804465 | 0.80 | L3MBTL1 (0.52) | APOBMTTP | |
| Hydrochloric Acid SCHEMBL6803617 | 0.79 | L3MBTL1 (0.51) | APOBMTTP | |
| SCHEMBL6665956 | 0.79 | RXFP1 (0.41) | APOBMTTPRXFP1PTGS1 | |
| SCHEMBL6803364 | 0.78 | GAA (0.61) | APOBMTTP | |
| SCHEMBL6803896 | 0.77 | APOB (0.51) | APOBMTTP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157866-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157866-A1 | Amide compounds | APOB, NR1H2, NR1H3 | APOB 1/4885MTTP 108/4885RXFP1 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.